From the Department of Neurosurgery (M.F., T.T., R.T., S.Y., A.T., Y.H.), Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan
From the Department of Neurosurgery (M.F., T.T., R.T., S.Y., A.T., Y.H.), Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan.
AJNR Am J Neuroradiol. 2023 Sep;44(9):1057-1063. doi: 10.3174/ajnr.A7944. Epub 2023 Aug 3.
Contrast-induced encephalopathy can result from neurotoxicity of contrast medium in the affected area. The development of intermediate catheters has allowed guidance of catheters to more distal arteries. This study focused on the association between contrast-induced encephalopathy and contrast injection from an intermediate catheter guided into a distal intradural artery during neurointervention for cerebral aneurysms.
We retrospectively reviewed 420 consecutive aneurysms in 396 patients who underwent neurointervention for extracranial aneurysms and unruptured intracranial aneurysms at our institution from February 2012 to January 2023. Patients were divided into a group with contrast-induced encephalopathy and a group without. To identify risk factors for contrast-induced encephalopathy, we compared clinical, anatomic, and procedural factors between groups by multivariate logistic regression analysis and stepwise selection.
Among the 396 patients who underwent neurointervention for cerebral aneurysms, 14 (3.5%) developed contrast-induced encephalopathy. Compared with the group without contrast-induced encephalopathy, the group with contrast-induced encephalopathy showed significantly higher rates of patients on hemodialysis, previously treated aneurysms, intradural placement of a catheter for angiography, nonionic contrast medium, and flow-diversion procedures in univariate analyses. Stepwise multivariate logistic regression analysis revealed intradural placement of a catheter for angiography (OR = 40.4; 95% CI, 8.63-189) and previously treated aneurysms (OR = 8.20; 95% CI, 2.26-29.6) as independent predictors of contrast-induced encephalopathy.
Contrast injection from an intradural artery and retreatment of recurrent aneurysms were major risk factors for contrast-induced encephalopathy. Attention should be paid to the location of the intermediate catheter for angiography to avoid developing contrast-induced encephalopathy.
对比剂脑病可由受影响区域内对比剂的神经毒性引起。中间导管的发展使得导管能够引导至更远端的动脉。本研究重点关注在神经介入治疗脑动脉瘤期间,将中间导管引导至远端颅内动脉内注射对比剂与对比剂脑病之间的关联。
我们回顾性分析了 2012 年 2 月至 2023 年 1 月在我院接受颅外和未破裂颅内动脉瘤神经介入治疗的 396 例患者的 420 个连续动脉瘤。将患者分为对比剂脑病组和无对比剂脑病组。通过多变量逻辑回归分析和逐步选择,比较两组间的临床、解剖和手术因素,以确定对比剂脑病的危险因素。
在接受脑动脉瘤神经介入治疗的 396 例患者中,14 例(3.5%)发生对比剂脑病。与无对比剂脑病组相比,对比剂脑病组的血液透析患者、既往治疗过的动脉瘤、用于血管造影的颅内导管置管、非离子型对比剂和血流导向治疗的患者比例明显更高,单因素分析结果具有统计学意义。逐步多变量逻辑回归分析显示,用于血管造影的颅内导管置管(OR=40.4;95%CI,8.63-189)和既往治疗过的动脉瘤(OR=8.20;95%CI,2.26-29.6)是对比剂脑病的独立预测因素。
颅内动脉内注射对比剂和复发性动脉瘤的再治疗是对比剂脑病的主要危险因素。在进行血管造影时应注意中间导管的位置,以避免发生对比剂脑病。